Baur et al modified the Durie and Salmon Staging System for Multiple Myeloma by adding the findings of magnetic resonance imaging (MRI). This provides a useful prognostic tool for patients with multiple myeloma and can help identify patients who may require more aggressive therapy. The authors are from the University of Munich-Grosshadern in Munich, Germany.